Skip to main content
Year archive

MAXCYTE, INC. — 2018 filings

All 52 regulatory filings released by MAXCYTE, INC. (MXCT) in 2018, sourced directly from the official regulator.

52 Filings
2018 Period
2018 filings (52)
Filing Released Lang
Change of Auditor
Regulatory Filings
2018-12-19 English
Director Dealings
Director's Dealing
2018-12-17 English
Consolidation of Trading Lines
Share Issue/Capital Change
2018-11-21 English
Consolidation of Trading Lines
Share Issue/Capital Change
2018-11-21 English
Block Admission Six Monthly Return/TVR
Regulatory Filings
2018-11-20 English
Block Admission Six Monthly Return/TVR
Regulatory Filings
2018-11-20 English
Webinar: non-viral cell engineering
Regulatory Filings
2018-11-16 English
Webinar: non-viral cell engineering
Regulatory Filings
2018-11-16 English
Clinical and Commercial License Agreement
Regulatory Filings
2018-11-14 English
Clinical and Commercial License Agreement
Regulatory Filings
2018-11-14 English
MaxCyte Announces Research Agreement with Kite
Regulatory Filings
2018-11-12 English
MaxCyte Announces Research Agreement with Kite
Regulatory Filings
2018-11-12 English
Expansion of CRISPR Commercial License Agreement
Regulatory Filings
2018-11-09 English
Expansion of CRISPR Commercial License Agreement
Regulatory Filings
2018-11-09 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements
2018-10-31 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements
2018-10-31 English
Dosing Begins in First Clinical Trial of MCY-M11
Regulatory Filings
2018-10-10 English
Dosing Begins in First Clinical Trial of MCY-M11
Regulatory Filings
2018-10-10 English
Notice of AGM
AGM Information
2018-10-08 English
Notice of AGM
AGM Information
2018-10-08 English
Results for the Half Year ended 30 June 2018
Interim / Quarterly Report H1 2018
2018-09-24 English
Results for the Half Year ended 30 June 2018
Interim / Quarterly Report H1 2018
2018-09-24 English
Grant of Options
Director's Dealing
2018-09-10 English
Grant of Options
Director's Dealing
2018-09-10 English
Notice of Half Year Results
Report Publication Announcement
2018-09-03 English
Notice of Half Year Results
Report Publication Announcement
2018-09-03 English
Director/PDMR Shareholding
Director's Dealing
2018-07-26 English
Director/PDMR Shareholding
Director's Dealing
2018-07-26 English
FDA IND Clearance for First Clinical Programme
Regulatory Filings
2018-07-16 English
Trading Update
Regulatory Filings
2018-07-16 English
Trading Update
Regulatory Filings
2018-07-16 English
FDA IND Clearance for First Clinical Programme
Regulatory Filings
2018-07-16 English
MaxCyte & NIH enter CRADA for Sickle Cell Disease
Regulatory Filings
2018-06-11 English
Preclinical Results at ASGCT Annual Meeting
Regulatory Filings
2018-05-21 English
Notice of AGM and Annual Report
Report Publication Announcement
2018-04-30 English
Notice of AGM and Annual Report
Report Publication Announcement
2018-04-30 English
CMO Appointment
Board/Management Information
2018-04-25 English
Final Results for Year Ended 31 December 2017
Earnings Release FY 2017
2018-04-04 English
Final Results for Year Ended 31 December 2017
Earnings Release FY 2017
2018-04-04 English
Notice of Full Year Results
Report Publication Announcement
2018-03-15 English
Notice of Full Year Results
Report Publication Announcement
2018-03-15 English
Director/PDMR Shareholding
Director's Dealing
2018-02-28 English
Director/PDMR Shareholding
Director's Dealing
2018-02-28 English
Grant of Options
Director's Dealing
2018-02-15 English
Grant of Options
Director's Dealing
2018-02-15 English
Dr Richard Douglas Joins MaxCyte Board
Board/Management Information
2018-02-13 English
Dr Richard Douglas Joins MaxCyte Board
Board/Management Information
2018-02-13 English
Block listing Interim Review
Regulatory Filings
2018-02-01 English
Total Voting Rights
Share Issue/Capital Change
2018-01-23 English
Total Voting Rights
Share Issue/Capital Change
2018-01-23 English
Trading Update
Regulatory Filings
2018-01-22 English
Total Voting Rights
Share Issue/Capital Change
2018-01-12 English